VS
stockvs
Go to ScreenerHub
0QQ6.L

0QQ6.L vs ABBV

ABBV

In the past 12 months, ABBV returned +3% while 0QQ6.L gained 1%.

0QQ6.L
0QQ6.L

Roche Holding AG

$418.64
-10.9%(1M)
Market Cap356.9B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio45.65
ROE41.2%
P/B Ratio9.11
Dividend Yield3.0%
ABBV
ABBV

AbbVie Inc.

$221.45
-4.9%(1M)
Market Cap391.6B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio95.64
ROE-3.6%
P/B Ratio-123.60
Dividend Yield2.9%
Performance Comparison

Historical returns across multiple timeframes

ABBV leads 5/8
0QQ6.L

0QQ6.L

Roche Holding AG

+1.3%

1Y Return

ABBV

ABBV

AbbVie Inc.

+3.3%

1Y Return

0QQ6.L
0QQ6.L
ABBV
ABBV

Short Term

1M-6M

0QQ6.L
+3.9%

Medium Term

YTD-1Y

0QQ6.L
+0.5%

Long Term

3Y-10Y

ABBV
+145.2%

Valuation

Compare price multiples and valuation ratios

0QQ6.L: 4ABBV: 1
Metric0QQ6.LABBVWinner
P/E Ratio

Price to earnings ratio

45.6595.640QQ6.L
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.576.560QQ6.L
P/B Ratio

Price to book ratio

9.11-123.60ABBV
P/FCF Ratio

Price to free cash flow ratio

20.5921.460QQ6.L
EV/EBITDA

Enterprise value to EBITDA

12.7416.410QQ6.L
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

0QQ6.L: 6ABBV: 0
Metric0QQ6.LABBVWinner
Gross Margin

Gross profit margin

73.5%73.3%0QQ6.L
Operating Margin

Operating profit margin

28.4%26.7%0QQ6.L
Net Margin

Net profit margin

12.3%6.9%0QQ6.L
ROE

Return on equity

41.2%-3.6%0QQ6.L
ROA

Return on assets

12.8%3.2%0QQ6.L
ROIC

Return on invested capital

18.8%10.6%0QQ6.L

Growth

Compare revenue and earnings growth rates

0QQ6.L: 3ABBV: 3
Metric0QQ6.LABBVWinner
Revenue Growth (YoY)

Year-over-year revenue growth

-1.4%8.6%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

-0.9%1.8%ABBV
Revenue Growth (5Y)

5-year revenue CAGR

1.1%6.0%ABBV
EPS Growth (YoY)

Year-over-year EPS growth

55.9%-1.3%0QQ6.L
EPS Growth (3Y)

3-year EPS CAGR

1.1%-29.1%0QQ6.L
EPS Growth (5Y)

5-year EPS CAGR

-0.6%-2.8%0QQ6.L

Balance Sheet & Risk

Compare financial stability and debt levels

0QQ6.L: 4ABBV: 1
Metric0QQ6.LABBVWinner
Debt/Equity

Debt to equity ratio

1.21-21.06ABBV
Current Ratio

Current assets to current liabilities

1.290.670QQ6.L
Quick Ratio

Quick assets to current liabilities

1.020.560QQ6.L
Interest Coverage

EBIT to interest expense

10.735.770QQ6.L
Beta

Stock volatility vs market

0.210.330QQ6.L
Summary
0QQ6.L wins 3-0

Valuation

0QQ6.L

Profitability

0QQ6.L

Growth

Tie

Balance Sheet

0QQ6.L

0QQ6.L is more attractively valued. 0QQ6.L shows stronger profitability. 0QQ6.L has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into 0QQ6.L and ABBV with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/0QQ6.L/vs/ABBV" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare 0QQ6.L vs ABBV on stockvs.app
</a>